Critical Reviews in Oncogenesis : Impact Factor & More
eISSN: 2162-6448pISSN: 0893-9675
Share this on:
Key Metrics
CiteScore 
3
SJR
Q4Cancer Research
SNIP
0.44
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Critical Reviews in Oncogenesis
Critical Reviews in Oncogenesis Journal Specifications
| Overview | |
| Publisher | BEGELL HOUSE INC |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in Critical Reviews in Oncogenesis ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Critical Reviews in Oncogenesis
The Extracellular Matrix as a Barrier for CAR-T Cell Therapy in Solid Tumors
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
Does CAR T cell therapy of solid cancer need the activation of an innate immune response?
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
In Memoriam: Celebrating the Visionary Contributions of Zelig Eshhar, Pioneer of CAR T Cell Immunotherapy
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
In Memory to Prof. Zelig Eshhar (1941–2025), architect of CAR-T Therapy. The Evolution and Future of Immunotherapy: The Promise of CAR T Cell-Derived Extracellular Vesicles
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
Zelig Eshhar: The pioneer who re-engineered the T-cells and brought CAR-T into the world
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
Review Article: Understanding the Role of the Microbiome in Breast Cancer Progression.
- 1 Jan 2025
- Critical reviews in oncogenesis
The Extracellular Matrix as a Barrier for CAR-T Cell Therapy in Solid Tumors
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
Does CAR T cell therapy of solid cancer need the activation of an innate immune response?
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
In Memoriam: Celebrating the Visionary Contributions of Zelig Eshhar, Pioneer of CAR T Cell Immunotherapy
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
In Memory to Prof. Zelig Eshhar (1941–2025), architect of CAR-T Therapy. The Evolution and Future of Immunotherapy: The Promise of CAR T Cell-Derived Extracellular Vesicles
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
Zelig Eshhar: The pioneer who re-engineered the T-cells and brought CAR-T into the world
- 1 Jan 2026
- Critical Reviews™ in Oncogenesis
Review Article: Understanding the Role of the Microbiome in Breast Cancer Progression.
- 1 Jan 2025
- Critical reviews in oncogenesis
FAQs on Critical Reviews in Oncogenesis
What is the publishing frequency of Critical Reviews in Oncogenesis? 
How many articles did Critical Reviews in Oncogenesis publish last year?
What is the eISSN & pISSN for Critical Reviews in Oncogenesis?
What is Citescore for Critical Reviews in Oncogenesis?
What is SNIP score for Critical Reviews in Oncogenesis?
What is the SJR for Critical Reviews in Oncogenesis?
Who is the publisher of Critical Reviews in Oncogenesis?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations